Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 22.63% is 17% above its 5-year average of 19.29%, near the high end of its 5-year range (6.38%–26.41%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.43% above its 12-month average of 21.26%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
22.63%
NET PROFIT MARGIN AVG TTM
21.26%
NET PROFIT MARGIN AVG 3Y
18.39%
NET PROFIT MARGIN AVG 5Y
19.29%
NET PROFIT MARGIN AVG 10Y
19.38%
NET PROFIT MARGIN AVG 15Y
19.77%
NET PROFIT MARGIN AVG 20Y
19.89%
CURRENT VS TTM AVG
+6.43%
CURRENT VS 3Y AVG
+23.07%
CURRENT VS 5Y AVG
+17.32%
CURRENT VS 10Y AVG
+16.77%
CURRENT VS 15Y AVG
+14.47%
CURRENT VS 20Y AVG
+13.78%
SECTOR MEDIAN · HEALTHCARE
9.48%
median of 85 covered companies
CURRENT VS SECTOR MEDIAN
+138.70%
vs the sector median at left
Roche Holding AG
Market Cap
$359.46B
Net Profit Margin
22.63%
TTM Avg
21.26%
3Y Avg
18.39%
5Y Avg
19.29%
Market Cap
$358.76B
Net Profit Margin
3.14%
TTM Avg
3.15%
3Y Avg
4.63%
5Y Avg
5.09%
Market Cap
$369.34B
Net Profit Margin
4.78%
TTM Avg
27.40%
3Y Avg
19.98%
5Y Avg
20.62%
Market Cap
$255.15B
Net Profit Margin
17.02%
TTM Avg
15.23%
3Y Avg
12.72%
5Y Avg
10.53%
Market Cap
$235.85B
Net Profit Margin
22.93%
TTM Avg
16.61%
3Y Avg
20.49%
5Y Avg
22.20%
Market Cap
$234.38B
Net Profit Margin
15.06%
TTM Avg
14.95%
3Y Avg
14.84%
5Y Avg
16.47%
Market Cap
$205.42B
Net Profit Margin
35.33%
TTM Avg
33.96%
3Y Avg
33.83%
5Y Avg
33.74%
Market Cap
$193.04B
Net Profit Margin
11.65%
TTM Avg
23.34%
3Y Avg
19.20%
5Y Avg
17.71%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Roche Holding AG (RHHBY) | $359.46B | 22.63% | 21.26% | 18.39% | 19.29% |
| UnitedHealth Group Incorporated (UNH)vs › | $358.76B | 3.14% | 3.15% | 4.63% | 5.09% |
| Merck & Co., Inc. (MRK)vs › | $369.34B | 4.78% | 27.40% | 19.98% | 20.62% |
| AbbVie Inc. (ABBV)vs › | $455.87B | 9.81% | 7.25% | 10.96% | 12.41% |
| AstraZeneca PLC (AZN)vs › | $255.15B | 17.02% | 15.23% | 12.72% | 10.53% |
| Amgen Inc. (AMGN)vs › | $235.85B | 22.93% | 16.61% | 20.49% | 22.20% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $234.38B | 15.06% | 14.95% | 14.84% | 16.47% |
| Novo Nordisk A/S (NVO)vs › | $205.42B | 35.33% | 33.96% | 33.83% | 33.74% |
| Abbott Laboratories (ABT)vs › | $193.04B | 11.65% | 23.34% | 19.20% | 17.71% |
| Gilead Sciences, Inc. (GILD)vs › | $184.82B | -10.64% | 15.29% | 17.07% | 15.27% |
Operating Margin
29.2%
Net Profit Margin
22.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 22.63% |
| 2025-12-31 | 17.89% |
| 2025-06-30 | 23.27% |
| 2024-12-31 | 6.38% |
| 2024-06-30 | 20.35% |
| 2023-12-31 | 14.22% |
| 2023-06-30 | 23.97% |
| 2022-12-31 | 12.56% |
| 2022-06-30 | 26.41% |
| 2021-12-31 | 19.09% |
| 2021-06-30 | 25.41% |
| 2020-12-31 | 21.40% |
| 2020-06-30 | 27.59% |
| 2019-12-31 | 15.74% |
| 2019-06-30 | 27.15% |
| 2018-12-31 | 10.65% |
| 2018-06-30 | 24.75% |
| 2017-12-31 | 11.19% |
| 2017-06-30 | 19.88% |
| 2016-12-31 | 15.77% |
| 2016-06-30 | 20.68% |
| 2015-12-31 | 14.50% |
| 2015-06-30 | 20.76% |
| 2014-12-31 | 14.90% |
| 2014-06-30 | 22.70% |
| 2013-12-31 | 21.44% |
| 2013-06-30 | 24.50% |
| 2012-12-31 | 21.66% |
| 2012-06-30 | 21.48% |
| 2011-12-31 | 21.48% |
| 2011-06-30 | 22.44% |
| 2010-12-31 | 22.44% |
| 2010-06-30 | 18.73% |
| 2009-12-31 | 18.73% |
| 2009-06-30 | 17.35% |
| 2008-12-31 | 15.55% |
| 2008-06-30 | 23.77% |
| 2007-12-31 | 23.77% |
| 2007-06-30 | 24.79% |
| 2006-12-31 | 15.72% |
| 2006-06-30 | 21.77% |
| 2005-12-31 | 18.92% |
| 2005-06-30 | 18.99% |
| 2004-12-31 | 18.99% |
| 2004-06-30 | 22.83% |
| 2003-12-31 | 8.65% |
| 2003-06-30 | 11.01% |
| 2002-12-31 | -13.52% |
| 2002-06-30 | -13.57% |
| 2001-12-31 | 12.58% |
| 2001-06-30 | 12.77% |
| 2000-12-31 | 35.22% |
| 2000-06-30 | 25.10% |
| 1999-12-31 | 21.31% |
| 1999-06-30 | 20.51% |
| 1998-12-31 | 20.51% |
| 1998-06-30 | 18.20% |
| 1998-01-31 | 18.20% |
